Susquehanna International Group, LLP Design Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$1.99 - $2.76 $17,313 - $24,011	-8,700 Reduced 8.69%	91,400 $242,000
Q3 2023 Nov 14, 2023	BUY	$2.05 - $8.14 $205,204 - $814,814	100,100 New	100,100 $236,000
Q4 2022 Feb 14, 2023	BUY	$7.86 - $17.2 $190,998 - $417,960	24,300 Added 15.23%	183,900 $1.89 Million
Q3 2022 Nov 14, 2022	BUY	$14.09 - $25.57 $1.42 Million - $2.57 Million	100,500 Added 170.05%	159,600 $2.67 Million
Q2 2022 Aug 15, 2022	BUY	$9.91 - $17.33 $585,681 - $1.02 Million	59,100 New	59,100 $827,000

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $347M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.